Everolimus alleviates cognitive dysfunction in 5×FAD mice by regulating mitochondrial function and oxidative stress

Area of Science:

• Neuroscience
• Pharmacology
• Aging Research

Background:

• Mammalian target of rapamycin (mTOR) inhibitors show potential in combating age-related diseases.
• The effects of Everolimus on cognitive function and its mechanisms are not fully understood.
• Alzheimer's disease is a major cause of cognitive dysfunction.

Purpose of the Study:

• To investigate the impact of Everolimus on cognitive abilities in a mouse model of Alzheimer's disease (5x FAD mice).
• To explore the underlying mechanisms by which Everolimus might affect cognitive function.

Main Methods:

• 5x FAD mice were administered varying doses of Everolimus via intraperitoneal injection every other day for 8 weeks.
• Cognitive abilities, including learning and spatial memory, were systematically evaluated.
• Hippocampal morphology and cell counts were analyzed post-treatment.

Main Results:

• Everolimus administration significantly improved learning and spatial memory in 5x FAD mice.
• Histological analysis revealed normal hippocampal morphology and an increased number of pyramidal cells.
• Improvements were linked to enhanced mitochondrial function, reduced oxidative stress, and better energy metabolism in hippocampal tissues.

Conclusions:

• Everolimus alleviates cognitive impairment in 5x FAD mice, suggesting a therapeutic potential for Alzheimer's disease.
• The drug enhances cognitive function by promoting mitochondrial bioenergetics and mitigating oxidative stress.
• Future research should explore the roles of autophagy and mitophagy in Everolimus's mechanism of action.